Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126603) titled 'Phase ? Clinical Study on the Efficacy and Safety of SBRT Combined With Vibecotamab in EGFR-Positive Metastatic Tumor Patients With Oligometastases' on June 12.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Condition:
For patients with EGFR-positive malignant tumors and oligometastases whose primary lesion has been radically treated and is well-controlled.
Intervention:
Trial group:Becotatug vedotin plus SBRT and investigator's choice of treatment regimen
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2026-...